Insulin receptor kinase complexed with an inhibitor
The structure was published by Chamberlain, S.D., Wilson, J.W., Deanda, F., et al., Stevens, K.L., Kumar, R., and Shotwell, J.B., in 2009 in a paper entitled "Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase." (abstract).
This crystal structure was determined using X-ray diffraction at a resolution of 2.1 Å and deposited in 2008.
The experimental data on which the structure is based was also deposited.
The PDB entry contains the structure of Insulin receptor. This molecule has the UniProt identifier P06213 (INSR_HUMAN). The sample contained 307 residues which is < 90% of the natural sequence. Out of 307 residues 282 were observed and are deposited in the PDB.
It also contains one or more heterogenic compounds (e.g., ligands, co-factors, ions, modified amino acids, etc.); see here for a complete list.
The molecule is most likely monomeric.
The following tables show cross-reference information to other databases (to obtain a list of all PDB entries sharing the same property or classification, click on the magnifying glass icon):